Pretransplant Mixed Lymphocyte Culture Still Has an Impact on Graft Survival

Background/Aim: Mixed lymphocyte culture (MLC) is an important in vitro test for studying allograft reaction. The recipient-donor MLC reflects donor specific hypo- or hyperimmune response. The various studies have been correlated donor-specific MLC reactivity with graft survival in cadaver kidney transplantation. This retrospective study reports the relationship between of MLC hyper-responsiveness and graft survival in living-donor kidney transplantation. Methods: The study included 477 patients who underwent live-donor kidney transplantation between Marsh 1976 and January 2002. They were divided according to the relative response (RR) of pre transplant one way MLC into hypo responders (RR <4) and hyper responders (RR >4). The demographic and follow-up data for both groups were recorded. The duration of follow-up ranged from 44 to 84 months. Results: The two groups were homogenous regarding age, sex, donor source, HLA-A, B-and -DR mismatches, number of blood transfusion and type of 3 primary immunosuppressions. Acute rejection (AR) episodes were seen in 182 (44.8%) patients in the hypo-responders group, of whom 10 were steroid resistant, while in the hyper-responder recipients, AR episodes occurred in 33 patients (46.5%) of whom 5 patients (15.2%) were steroid resistant (p < 0.05). Chronic allograft nephropathy occurred in 14.5% and 27.3% and the actuarial 5-year graft survival was 79% and 60% (p = 0.03).in the hypo- and hyper-responder groups, respectively. Conclusions: It is concluded that MLC reaction may predict high-risk patients for immunological graft failure and that more potent immunosuppression should be considered in MLC hyper-responders.

[1]  T. Fujiwara,et al.  Donor specific hyporesponsiveness in a clinically tolerant renal transplant recipient. , 1999, Transplantation proceedings.

[2]  E. Benedetti,et al.  Pretransplant MLC in the presence of cyclosporine may predict renal allograft survival. , 1999, Transplantation proceedings.

[3]  R. Kapoor,et al.  In vitro pretransplant mixed lymphocyte culture response and acute rejection episodes. , 1998, Transplantation proceedings.

[4]  C. V. van Buren,et al.  Ten-year follow-up of mixed lymphocyte reaction-hyporesponsive living related cyclosporine monotherapy-treated renal allograft recipients. , 1997, Transplantation proceedings.

[5]  B. Kasiske,et al.  Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. , 1996, Kidney international.

[6]  A. Matas,et al.  EVIDENCE THAT IMPROVED LATE RENAL TRANSPLANT OUTCOME CORRELATES WITH THE DEVELOPMENT OF IN VITRO DONOR ANTIGEN‐SPECIFIC HYPOREACTIVITY , 1993, Transplantation.

[7]  P. Kimball,et al.  Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. , 1991, Transplantation.

[8]  M. Taniguchi,et al.  [Significance of histocompatibility tests]. , 1990, Rinsho byori. The Japanese journal of clinical pathology.

[9]  G. Clunie,et al.  ADVERSE INFLUENCE OF RECIPIENT LYMPHOID RESISTANCE TO IN VITRO IMMUNOSUPPRESSION ON THE OUTCOME OF KIDNEY TRANSPLANTS , 1988, Transplantation.

[10]  S. Flechner,et al.  THE USE OF CYCLOSPORINE IN LIVING‐RELATED RENAL TRANSPLANTATION: Donor‐Specific Hyporesponsiveness and Steroid Withdrawal , 1984, Transplantation.

[11]  P. Lavin,et al.  Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. , 1982, Journal of immunology.

[12]  O. Jonasson,et al.  Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants. , 1981, Transplantation proceedings.